Shaolin Capital Management’s Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant WEL.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-225,000
Closed -$2.27M 1155
2021
Q4
$2.27M Buy
+225,000
New +$2.27M 0.06% 376

Other funds holding WEL.U

Shaolin Capital Management's WEL.U Position: Q1 2022 in Review

Shaolin Capital Management sold out of Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (WEL.U) in Q1 2022, closing a stake of 225,000 shares — an estimated $2.27M sold.

Shaolin Capital Management first reported a position in WEL.U in Q4 2021 and held it in 1 quarter. The position peaked at $2.27M in Q4 2021. 18 funds tracked by Wall St. Rank hold WEL.U as of Q1 2022.

  • Shaolin Capital Management reported no remaining Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
  • Shaolin Capital Management sold 225,000 Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q1 2022, an estimated $2.27M.
  • Shaolin Capital Management first reported a position in Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q4 2021 and held it in 1 quarter.
  • Shaolin Capital Management's Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $2.27M in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q1 2022.

Based on Shaolin Capital Management's 13F filing for Q1 2022, filed 13 May 2022.